Monkeypox: The Next Healthcare Challenge – Understanding and Reckoning With It – A Foreign Policy Association Special Report
Posted: Sep 22nd, 2022In: Press ReleasesMonkeypox: The Next Healthcare Challenge – Understanding and Reckoning With It was published today as a Special Report by the Foreign Policy Association on the organization’s Web site.
Read More about Monkeypox: The Next Healthcare Challenge – Understanding and Reckoning With It – A Foreign Policy Association Special ReportWBB SECURITIES ACTS AS CO-MANAGER IN A $45 MILLION PUBLIC OFFERING, PRE-FUNDED WARRANTS AND WARRANTS FOR SCYNEXIS, INC.
Posted: Apr 26th, 2022In: Press ReleasesWBB Securities acted as co-manager for a public offering, pre-funded warrants and warrants for SCYNEXIS, Inc.
Read More about WBB SECURITIES ACTS AS CO-MANAGER IN A $45 MILLION PUBLIC OFFERING, PRE-FUNDED WARRANTS AND WARRANTS FOR SCYNEXIS, INC.WBB Securities and WBB Research Institute Sponsors Demy-Colton’s Virtual Salon: Getting to the Next Normal: A Roadmap for Living with COVID
Posted: Mar 17th, 2022In: Press ReleasesThe Salon will feature three of the authors of a new, definitive report on the future of COVID, titled Getting to the Next Normal: A Roadmap for Living with COVID.
Read More about WBB Securities and WBB Research Institute Sponsors Demy-Colton’s Virtual Salon: Getting to the Next Normal: A Roadmap for Living with COVIDSteve Brozak, President of WBB Securities participated in a Biotech Showcase session titled, Covid: What Happens Next?
Posted: Jan 12th, 2022In: Press ReleasesSteve Brozak, President of WBB Securities today participated in a Biotech Showcase session titled, Covid: What Happens Next?
Read More about Steve Brozak, President of WBB Securities participated in a Biotech Showcase session titled, Covid: What Happens Next?WBB Securities Sponsors The Annual Biotech Showcase: The Investor Conference for Innovations 2022
Posted: Jan 10th, 2022In: Press ReleasesWBB Securities is a sponsor of this year’s Biotech Showcase.
Read More about WBB Securities Sponsors The Annual Biotech Showcase: The Investor Conference for Innovations 2022WBB Securities President Steve Brozak will Moderate a panel at the BioFuture Conference on Wednesday, October 6, 2021
Posted: Oct 5th, 2021In: Press ReleasesSteve Brozak, DMH, Managing Partner and President of WBB Securities will moderate a panel at BioFuture on October 6, 2021.
Read More about WBB Securities President Steve Brozak will Moderate a panel at the BioFuture Conference on Wednesday, October 6, 2021WBB Securities President Steve Brozak Gives A SARS-CoV-2 Presentation Followed By A Q&A Session At Columbia University.
Posted: May 19th, 2021In: Press ReleasesSteve Brozak, the Managing Partner and President of WBB Securities gave a comprehensive presentation about SARS-CoV-2 at Columbia University...
Read More about WBB Securities President Steve Brozak Gives A SARS-CoV-2 Presentation Followed By A Q&A Session At Columbia University.WBB Securities Sponsors Demy-Colton Virtual Salon “Sepsis: A Critical Healthcare Burden Needing Rapid Diagnoses to Improve Patient Outcomes”
Posted: Mar 25th, 2021In: Press ReleasesWBB Securities, sponsored a Demy-Colton Virtual Salon focused on the critical need for point-of-care...
Read More about WBB Securities Sponsors Demy-Colton Virtual Salon “Sepsis: A Critical Healthcare Burden Needing Rapid Diagnoses to Improve Patient Outcomes”WBB Securities President Steve Brozak will moderate a Live Forum at Biotech Showcase today.
Posted: Jan 6th, 2021In: Press ReleasesSteve Brozak, Managing Partner and President of WBB Securities, LLC will moderate a live forum at Biotech Showcase on January 6, 2021.
Read More about WBB Securities President Steve Brozak will moderate a Live Forum at Biotech Showcase today.WBB Securities Acts As Co-Manager In a $85 Million Public Offering, Pre-Funded Warrants and Warrants For SCYNEXIS, Inc.
Posted: Dec 22nd, 2020In: Press ReleasesWBB Securities Acts As Co-Manager In a $85 Million Public Offering...
Read More about WBB Securities Acts As Co-Manager In a $85 Million Public Offering, Pre-Funded Warrants and Warrants For SCYNEXIS, Inc.